Overview
+pharma Polska sp. z o.o. is based in Kraków and forms part of the Austrian pharmaceutical group Genericon Pharma, operating in Poland since 2009. The company markets prescription medicines used in urology, psychiatry and neurology, as well as MULTI dietary supplements. Every stage, from product registration through production to logistics, is closely controlled to meet strict quality requirements.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $290,280 | |
| Profit allocation | Retained in reserve capital | |
| Foreign sales | 100% of revenue ($11,931,970) | |
| Related parties | 1 items |
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 472 days for 2020). 4 of 6 audited by a statutory auditor.
- 202524/06/2026
- 202421/10/2025
- 202331/07/2024
- 202231/07/2024
- 202130/01/2023
- 202030/01/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Prescription medicines
- Antibiotics
- Antipsychotic medicines
- Antidepressants
- Dietary supplements
Websites
- pluspharma.pl+pharma PolskaApache
Job offers
The company has its own careers page: pluspharma.pl/kariera.php.
Authorized Representatives
Manner of representation
If the company has a one-person management board, the member of the management board represents the company independently. If the company's management board is multi-member, joint action by two members of the management board or by one member jointly with a commercial proxy is required to represent the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
+pharma Arzneimittel Gesellschaft Mit Beschränkter Haftung | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-01-01.
66 1750 0009 0000 0000 1092 4405
44 1750 0009 0000 0000 1092 4413
22 1750 0009 0000 0000 1092 4421
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 5, 2015 | Call to creditors | |
| Mar 11, 2014 | Call to creditors |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $28,713$28,713 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $47,184$47,184 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $25,236$25,236 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Angelini Pharma Polska sp. z o.o. | $119,629,315.69 | angelinipharma.pl | ||
| MIP Pharma Polska sp. z o.o. | $17,756,306.34 | mip-pharma.de | ||
| Biofarm - Hurt sp. z o.o. | $14,585,127.56 | biofarm.pl | ||
| Vipado sp. z o.o. | $11,385,128.54 | vipado.pl | ||
| Dicofarm Polska sp. z o.o. | $9,478,812.54 | dicofarm.pl | ||
| Ibsa Poland sp. z o.o. | $8,664,746.04 | ibsapoland.pl | ||
| Grindeks Kalceks Polska sp. z o.o. | $6,256,560.67 | grindeks.pl | ||
| Noris Polska sp. z o.o. | $4,417,954.24 | norispolska.pl | ||
| Prima-Pharma sp. z o.o. | $1,648,108.34 | primapharma.pl | ||
| Pharmaselect Polska sp. z o.o. | $1,515,948.26 | pharmaselect.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-04-22 | Share capital increase (49,500.00 PLN → 50,000.00 PLN) | |
| 2016-04-22 | PKD change (Removed: 21 codes) | |
| 2015-05-27 | Share capital reduction (50,000.00 PLN → 49,500.00 PLN) | |
| 2012-06-08 | Address change (Zawiła 61, 30-390, Kraków → Podgórska 34, 31-536, Kraków) | |
| 2009-03-20 | Address change (Łazienna 24/2, 87-100, Toruń → Zawiła 61, 30-390, Kraków) |
FAQ
Last updated: 2026-10-07